Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline + ambroxol for Dementia with Lewy bodies
ACTRN12623000004662Phase 2Recruiting
- Sponsor
- Macquarie University
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of doxycycline and ambroxol in dementia with Lewy bodies (DLB) (2 arms), sponsored by Macquarie University. Primary endpoints: Feasibility of trial protocol and Tolerability and safety. Started Oct 2023; status: recruiting.
02
Drugs
doxycyclineambroxol
03
Conditions
dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on ACTRN12623000004662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000004662.